ADC Therapeutics (ADCT) Times Interest Earned (2020 - 2026)
ADC Therapeutics (ADCT) posted quarterly Times Interest Earned of -$2.04 for Q1 2026, up 12.16% year-on-year from -$1.82 in Q1 2025, and up 11.6% on a QoQ basis from -$2.31 in Q3 2025.
ADC Therapeutics (ADCT) Times Interest Earned (2020 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Times Interest Earned for 7 consecutive years, with -$2.04 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned rose 12.16% year-over-year to -$2.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.83 (down 248.21% YoY) and the FY2022 annual result came in at -$0.16, up 98.59% from the prior year.
- Times Interest Earned advanced to -$2.04 in Q1 2026 per ADCT's latest filing, from -$2.31 in the prior quarter.
- Over the last five years, Times Interest Earned for ADCT reached as high as -$0.27 in Q3 2022 and fell as low as -$7.89 in Q2 2022.
- A 5-year average of -$3.32 and a median of -$2.77 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned jumped 97.98% — and 2023, when it tumbled 928.61%.
- Year by year, Times Interest Earned stood at -$4.58 in 2022, then surged by 38.4% to -$2.82 in 2023, then increased by 3.88% to -$2.71 in 2024, then rose by 14.71% to -$2.31 in 2025, then climbed by 11.6% to -$2.04 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$2.04, -$2.31, and -$3.4 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | -2.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.04 |
| Sep 30, 2025 | -2.31 |
| Jun 30, 2025 | -3.40 |
| Mar 31, 2025 | -2.33 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -2.29 |
| Mar 31, 2024 | -2.69 |
| Sep 30, 2023 | -2.82 |
| Jun 30, 2023 | -3.85 |
| Mar 31, 2023 | -4.95 |
| Dec 31, 2022 | -4.58 |
| Sep 30, 2022 | -0.27 |
| Jun 30, 2022 | -7.89 |
| Mar 31, 2022 | -4.38 |
| Dec 31, 2021 | -2.73 |
| Sep 30, 2021 | -13.55 |
| Jun 30, 2021 | -27.59 |
| Mar 31, 2021 | -31.85 |
| Dec 31, 2020 | -26.48 |
| Sep 30, 2020 | -27.02 |